Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs KRMN✓SelectedUSD · KRMNGSK vs KRMN performance historyLatest closeAs of-2.32%11/17
Stock and ETF performance explorer

GSK vs KRMN

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+45.5%
KRMN return
+18.5%
Excess return
+27.0%
Maximum drawdown
-22.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioKRMNExcessAlpha
1D-2.3%-5.2%+2.9%-2.2%
7D-3.0%-19.0%+16.0%-2.5%
30D+0.4%+2.5%-2.2%-0.1%
3M-1.2%-42.5%+41.3%+0.6%
6M+0.9%-43.4%+44.3%+2.5%
YTD+4.0%-51.4%+55.4%+4.7%
1Y+7.3%-39.0%+46.3%+6.8%
All+45.5%+18.5%+27.0%+38.6%

Cumulative growth

Daily Returns

Daily percentage return beside KRMN.

Daily Out/Under-Performance

Portfolio return minus KRMN return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × KRMN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded KRMN wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling